{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:24:41Z","timestamp":1790342681270,"version":"4.1.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shanghai Sailing Program","award":["24YF2755600"],"award-info":[{"award-number":["24YF2755600"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2024M763421"],"award-info":[{"award-number":["2024M763421"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Strategic Priority Research Program of the Chinese Academy of sciences","award":["XDB1260301"],"award-info":[{"award-number":["XDB1260301"]}]},{"name":"Strategic Priority Research Program of the Chinese Academy of sciences","award":["XDB0830000"],"award-info":[{"award-number":["XDB0830000"]}]},{"DOI":"10.13039\/501100004739","name":"Youth Innovation Promotion Association CAS","doi-asserted-by":"crossref","award":["2023296"],"award-info":[{"award-number":["2023296"]}],"id":[{"id":"10.13039\/501100004739","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Research Funds of Hangzhou Institute for Advanced Study","award":["2025HIAS-ZL007"],"award-info":[{"award-number":["2025HIAS-ZL007"]}]},{"name":"Research Funds of Hangzhou Institute for Advanced Study, UCAS","award":["2025HIAS-ZL018"],"award-info":[{"award-number":["2025HIAS-ZL018"]}]},{"name":"Lingang Laboratory","award":["LGL-8888"],"award-info":[{"award-number":["LGL-8888"]}]},{"name":"Key Technologies R D Program of Guangdong Province","award":["2023B1111030004"],"award-info":[{"award-number":["2023B1111030004"]}]},{"name":"Shanghai Municipal Science and Technology Major Project"},{"name":"Innovative Drug Research and Development \u2014 National Science and Technology Major Project","award":["2025ZD1801200"],"award-info":[{"award-number":["2025ZD1801200"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82204278"],"award-info":[{"award-number":["82204278"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-026-02735-x","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:38:17Z","timestamp":1778675897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multimodal interpretable deep learning for transcriptome-informed precision oncology and drug mechanism analysis"],"prefix":"10.1038","volume":"9","author":[{"given":"Ning","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochu","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaokun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lehan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xutong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"2735_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrg.2016.86","volume":"17","author":"EA Ashley","year":"2016","unstructured":"Ashley, E. A. Towards precision medicine. Nat. Rev. Genet. 17, 507\u2013522 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"2735_CR2","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"2735_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack, I. & Shaw, A. T. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 15, 81\u201394 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2735_CR4","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.annonc.2021.04.003","volume":"32","author":"A Haslam","year":"2021","unstructured":"Haslam, A., Kim, M. S. & Prasad, V. Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020. Ann. Oncol. 32, 926\u2013932 (2021).","journal-title":"Ann. Oncol."},{"key":"2735_CR5","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.molmed.2017.08.003","volume":"23","author":"D Senft","year":"2017","unstructured":"Senft, D., Leiserson, M. D. M., Ruppin, E. & Ronai, Z. E. A. Precision oncology: the road ahead. Trends Mol. Med. 23, 874\u2013898 (2017).","journal-title":"Trends Mol. Med."},{"key":"2735_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ccell.2020.09.014","volume":"38","author":"BM Kuenzi","year":"2020","unstructured":"Kuenzi, B. M. et al. Predicting drug response and synergy using a deep learning model of human cancer cells. Cancer Cell 38, 672\u2013684.e676 (2020).","journal-title":"Cancer Cell"},{"key":"2735_CR7","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1093\/jnci\/djz114","volume":"111","author":"VTG Lin","year":"2019","unstructured":"Lin, V. T. G. & Yang, E. S. The pros and cons of incorporating transcriptomics in the age of precision oncology. J. Natl. Cancer Inst. 111, 1016\u20131022 (2019).","journal-title":"J. Natl. Cancer Inst."},{"key":"2735_CR8","doi-asserted-by":"crossref","unstructured":"Chen, Y. & Zhang, L. How much can deep learning improve prediction of the responses to drugs in cancer cell lines? Brief. Bioinform. 23, bbab378 (2021).","DOI":"10.1093\/bib\/bbab378"},{"key":"2735_CR9","doi-asserted-by":"crossref","unstructured":"Jiang, L. et al. DeepTTA: a transformer-based model for predicting cancer drug response. Brief. Bioinform. 23, bbac100 (2022).","DOI":"10.1093\/bib\/bbac100"},{"key":"2735_CR10","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1021\/acs.jcim.1c00706","volume":"61","author":"I Jin","year":"2021","unstructured":"Jin, I. & Nam, H. HiDRA: hierarchical network for drug response prediction with attention. J. Chem. Inf. Model. 61, 3858\u20133867 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"2735_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33291-z","volume":"13","author":"S Chawla","year":"2022","unstructured":"Chawla, S. et al. Gene expression based inference of cancer drug sensitivity. Nat. Commun. 13, 5680 (2022).","journal-title":"Nat. Commun."},{"key":"2735_CR12","doi-asserted-by":"crossref","unstructured":"Campana, P. A. et al. Cancer drug sensitivity estimation using modular deep Graph Neural Networks. NAR Genom. Bioinform. 6, lqae043 (2024).","DOI":"10.1093\/nargab\/lqae043"},{"key":"2735_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37570-1","volume":"14","author":"N Moshkov","year":"2023","unstructured":"Moshkov, N. et al. Predicting compound activity from phenotypic profiles and chemical structures. Nat. Commun. 14, 1967 (2023).","journal-title":"Nat. Commun."},{"key":"2735_CR14","doi-asserted-by":"publisher","first-page":"3743","DOI":"10.1093\/bioinformatics\/btz158","volume":"35","author":"L Ramp\u00e1\u0161ek","year":"2019","unstructured":"Ramp\u00e1\u0161ek, L. et al. Dr.VAE: improving drug response prediction via modeling of drug perturbation effects. Bioinformatics 35, 3743\u20133751 (2019).","journal-title":"Bioinformatics"},{"key":"2735_CR15","doi-asserted-by":"publisher","first-page":"10010","DOI":"10.1093\/nar\/gkz805","volume":"47","author":"B Szalai","year":"2019","unstructured":"Szalai, B. et al. Signatures of cell death and proliferation in perturbation transcriptomics data-from confounding factor to effective prediction. Nucleic Acids Res. 47, 10010\u201310026 (2019).","journal-title":"Nucleic Acids Res."},{"key":"2735_CR16","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16342","volume":"11","author":"CU Joisa","year":"2023","unstructured":"Joisa, C. U. et al. Integrated single-dose kinome profiling data is predictive of cancer cell line sensitivity to kinase inhibitors. PeerJ 11, e16342 (2023).","journal-title":"PeerJ"},{"key":"2735_CR17","doi-asserted-by":"publisher","first-page":"1441558","DOI":"10.3389\/fgene.2024.1441558","volume":"15","author":"M Pak","year":"2024","unstructured":"Pak, M. et al. DGDRP: drug-specific gene selection for drug response prediction via re-ranking through propagating and learning biological network. Front. Genet. 15, 1441558 (2024).","journal-title":"Front. Genet."},{"key":"2735_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2025.101315","volume":"15","author":"J Yu","year":"2025","unstructured":"Yu, J. et al. DTLCDR: a target-based multimodal fusion deep learning framework for cancer drug response prediction. J. Pharm. Anal. 15, 101315 (2025).","journal-title":"J. Pharm. Anal."},{"key":"2735_CR19","doi-asserted-by":"publisher","first-page":"i130","DOI":"10.1093\/bioinformatics\/btae249","volume":"40","author":"D Bang","year":"2024","unstructured":"Bang, D., Koo, B. & Kim, S. Transfer learning of condition-specific perturbation in gene interactions improves drug response prediction. Bioinformatics 40, i130\u2013i139 (2024).","journal-title":"Bioinformatics"},{"key":"2735_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41551-023-01034-0","volume":"7","author":"JD Janizek","year":"2023","unstructured":"Janizek, J. D. et al. Uncovering expression signatures of synergistic drug responses via ensembles of explainable machine-learning models. Nat. Biomed. Eng. 7, 811\u2013829 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"2735_CR21","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s42256-019-0048-x","volume":"1","author":"C Rudin","year":"2019","unstructured":"Rudin, C. Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead. Nat. Mach. Intell. 1, 206\u2013215 (2019).","journal-title":"Nat. Mach. Intell."},{"key":"2735_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49620-3","volume":"15","author":"X Tong","year":"2024","unstructured":"Tong, X. et al. Deep representation learning of chemical-induced transcriptional profile for phenotype-based drug discovery. Nat. Commun. 15, 5378 (2024).","journal-title":"Nat. Commun."},{"key":"2735_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad461","volume":"25","author":"Q Ren","year":"2023","unstructured":"Ren, Q. et al. KinomeMETA: meta-learning enhanced kinome-wide polypharmacology profiling. Brief. Bioinform. 25, bbad461 (2023).","journal-title":"Brief. Bioinform."},{"key":"2735_CR24","doi-asserted-by":"publisher","first-page":"W489","DOI":"10.1093\/nar\/gkae380","volume":"52","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. KinomeMETA: a web platform for kinome-wide polypharmacology profiling with meta-learning. Nucleic Acids Res. 52, W489\u2013W497 (2024).","journal-title":"Nucleic Acids Res."},{"key":"2735_CR25","doi-asserted-by":"publisher","first-page":"8749","DOI":"10.1021\/acs.jmedchem.9b00959","volume":"63","author":"Z Xiong","year":"2020","unstructured":"Xiong, Z. et al. Pushing the boundaries of molecular representation for drug discovery with the graph attention mechanism. J. Med. Chem. 63, 8749\u20138760 (2020).","journal-title":"J. Med. Chem."},{"key":"2735_CR26","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","volume":"171","author":"A Subramanian","year":"2017","unstructured":"Subramanian, A. et al. A next generation connectivity map: L1000 platform and the first 1,000,000 profiles. Cell 171, 1437\u20131452.e1417 (2017).","journal-title":"Cell"},{"key":"2735_CR27","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1126\/science.1095920","volume":"303","author":"MEM Noble","year":"2004","unstructured":"Noble, M. E. M., Endicott, J. A. & Johnson, L. N. Protein kinase inhibitors: insights into drug design from structure. Science 303, 1800\u20131805 (2004).","journal-title":"Science"},{"key":"2735_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/nrd773","volume":"1","author":"P Cohen","year":"2002","unstructured":"Cohen, P. Protein kinases \u2014 the major drug targets of the twenty-first century? Nat. Rev. Drug Discov. 1, 309\u2013315 (2002).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2735_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/1087057105282300","volume":"11","author":"DH Young","year":"2006","unstructured":"Young, D. H., Rubio, F. M. & Danis, P. O. A Radioligand binding assay for antitubulin activity in tumor cells. J. Biomol. Screen. 11, 82\u201389 (2006).","journal-title":"J. Biomol. Screen."},{"key":"2735_CR30","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1021\/jm3014597","volume":"56","author":"JAD Good","year":"2013","unstructured":"Good, J. A. D. et al. Optimized S-trityl-l-cysteine-based inhibitors of kinesin spindle protein with potent in vivo antitumor activity in lung cancer xenograft models. J. Med. Chem. 56, 1878\u20131893 (2013).","journal-title":"J. Med. Chem."},{"key":"2735_CR31","first-page":"1493","volume":"19","author":"A Wallin","year":"2008","unstructured":"Wallin, A. et al. Anticancer effect of SN-38 on colon cancer cell lines with different metastatic potential. Oncol. Rep. 19, 1493\u20131498 (2008).","journal-title":"Oncol. Rep."},{"key":"2735_CR32","doi-asserted-by":"publisher","first-page":"104904","DOI":"10.1016\/j.jddst.2023.104904","volume":"91","author":"X Qi","year":"2024","unstructured":"Qi, X. et al. Macrophage membrane-coated SN-38-encapsulated liposomes for efficient treatment of colorectal cancer. J. Drug Deliv. Sci. Technol. 91, 104904 (2024).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"2735_CR33","doi-asserted-by":"publisher","first-page":"PR-2","DOI":"10.1158\/1535-7163.TARG-09-PR-2","volume":"8","author":"C Guo","year":"2009","unstructured":"Guo, C. et al. Abstract PR-2: discovery of p21-activated kinase inhibitor PF-03758309. Mol. Cancer Ther. 8, PR-2\u2013PR-2 (2009).","journal-title":"Mol. Cancer Ther."},{"key":"2735_CR34","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1016\/0006-2952(85)90540-4","volume":"34","author":"H Tawfik","year":"1985","unstructured":"Tawfik, H., Fox, A. A. L. & Greeff, K. Comparative studies of some semisynthetic K-strophanthins with natural cardiac glycosides. Biochem. Pharmacol. 34, 2541\u20132547 (1985).","journal-title":"Biochem. Pharmacol."},{"key":"2735_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00280-017-3337-2","volume":"80","author":"L Pan","year":"2017","unstructured":"Pan, L. et al. The cardiac glycoside oleandrin induces apoptosis in human colon cancer cells via the mitochondrial pathway. Cancer Chemother. Pharmacol. 80, 91\u2013100 (2017).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"2735_CR36","doi-asserted-by":"publisher","first-page":"180","DOI":"10.2174\/1386207319666160202120928","volume":"19","author":"J Xie","year":"2016","unstructured":"Xie, J., Wang, C. & Gore, C. J. High throughput screening for colorectal cancer specific compounds. Comb. Chem. High Throughput Screen. 19, 180\u2013188 (2016).","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"2735_CR37","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41586-023-06139-9","volume":"618","author":"CV Theodoris","year":"2023","unstructured":"Theodoris, C. V. et al. Transfer learning enables predictions in network biology. Nature 618, 616\u2013624 (2023).","journal-title":"Nature"},{"key":"2735_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1189\/jlb.0705409","volume":"80","author":"M Leiba","year":"2006","unstructured":"Leiba, M. et al. Halofuginone inhibits NF-\u03baB and p38 MAPK in activated T cells. J. Leukoc. Biol. 80, 399\u2013406 (2006).","journal-title":"J. Leukoc. Biol."},{"key":"2735_CR39","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.scib.2024.11.020","volume":"70","author":"H Wang","year":"2025","unstructured":"Wang, H. et al. Integrative proteogenomic and pharmacological landscape of acute myeloid leukaemia. Sci. Bull. 70, 1051\u20131056 (2025).","journal-title":"Sci. Bull."},{"key":"2735_CR40","doi-asserted-by":"crossref","unstructured":"Wang, C.-C., Zhao, Y. & Chen, X. Drug-pathway association prediction: from experimental results to computational models. Brief. Bioinform. 22, bbaa061 (2020).","DOI":"10.1093\/bib\/bbaa061"},{"key":"2735_CR41","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.semcancer.2022.04.002","volume":"85","author":"E Levantini","year":"2022","unstructured":"Levantini, E., Maroni, G., Del Re, M. & Tenen, D. G. EGFR signaling pathway as therapeutic target in human cancers. Semin. Cancer Biol. 85, 253\u2013275 (2022).","journal-title":"Semin. Cancer Biol."},{"key":"2735_CR42","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejmech.2014.09.051","volume":"87","author":"R Kaur","year":"2014","unstructured":"Kaur, R. et al. Recent developments in tubulin polymerization inhibitors: an overview. Eur. J. Med. Chem. 87, 89\u2013124 (2014).","journal-title":"Eur. J. Med. Chem."},{"key":"2735_CR43","doi-asserted-by":"publisher","first-page":"113495","DOI":"10.1016\/j.ejmech.2021.113495","volume":"221","author":"T Pradhan","year":"2021","unstructured":"Pradhan, T., Gupta, O., Singh, G. & Monga, V. Aurora kinase inhibitors as potential anticancer agents: recent advances. Eur. J. Med. Chem. 221, 113495 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"2735_CR44","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1634\/theoncologist.2-6-359","volume":"2","author":"RB Ewesuedo","year":"1997","unstructured":"Ewesuedo, R. B. & Ratain, M. J. Topoisomerase I inhibitors. Oncologist 2, 359\u2013364 (1997).","journal-title":"Oncologist"},{"key":"2735_CR45","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1631\/jzus.B2200465","volume":"24","author":"W Cao","year":"2023","unstructured":"Cao, W. et al. CUDC-101 as a dual-target inhibitor of EGFR and HDAC enhances the anti-myeloma effects of bortezomib by regulating G2\/M cell cycle arrest. J. Zhejiang Univ. Sci. B 24, 442\u2013454 (2023).","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"2735_CR46","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1158\/1535-7163.MCT-19-0273","volume":"18","author":"R Roy","year":"2019","unstructured":"Roy, R., Winteringham, L. N., Lassmann, T. & Forrest, A. R. R. Expression levels of therapeutic targets as indicators of sensitivity to targeted therapeutics. Mol. Cancer Ther. 18, 2480\u20132489 (2019).","journal-title":"Mol. Cancer Ther."},{"key":"2735_CR47","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/s41589-022-01048-w","volume":"18","author":"Z Feng","year":"2022","unstructured":"Feng, Z. et al. Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1. Nat. Chem. Biol. 18, 1065\u20131075 (2022).","journal-title":"Nat. Chem. Biol."},{"key":"2735_CR48","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1124\/dmd.110.034678","volume":"38","author":"D Stagos","year":"2010","unstructured":"Stagos, D. et al. Aldehyde dehydrogenase 1B1: molecular cloning and characterization of a novel mitochondrial acetaldehyde-metabolizing enzyme. Drug Metab. Dispos. 38, 1679\u20131687 (2010).","journal-title":"Drug Metab. Dispos."},{"key":"2735_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14346-z","volume":"12","author":"M Yang","year":"2022","unstructured":"Yang, M. et al. An integrative pan-cancer analysis of molecular characteristics and oncogenic role of mitochondrial creatine kinase 1A (CKMT1A) in human tumors. Sci. Rep. 12, 10025 (2022).","journal-title":"Sci. Rep."},{"key":"2735_CR50","doi-asserted-by":"crossref","unstructured":"Wu, Y. et al. Systematic pan-cancer analysis of the potential tumor diagnosis and prognosis biomarker P4HA3. Front. Genet. 14, 1045061 (2023).","DOI":"10.3389\/fgene.2023.1045061"},{"key":"2735_CR51","doi-asserted-by":"publisher","first-page":"6754","DOI":"10.3390\/ijms24076754","volume":"24","author":"M Owusu-Ansah","year":"2023","unstructured":"Owusu-Ansah, M. et al. NAGS, CPS1, and SLC25A13 (Citrin) at the crossroads of arginine and pyrimidines metabolism in tumor cells. Int. J. Mol. Sci. 24, 6754 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2735_CR52","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adf8016","volume":"17","author":"N Sun","year":"2024","unstructured":"Sun, N. et al. The aldehyde dehydrogenase ALDH1B1 exerts antiviral effects through the aggregation of the adaptor MAVS. Sci. Signal. 17, eadf8016 (2024).","journal-title":"Sci. Signal."},{"key":"2735_CR53","doi-asserted-by":"publisher","first-page":"e0121648","DOI":"10.1371\/journal.pone.0121648","volume":"10","author":"S Singh","year":"2015","unstructured":"Singh, S. et al. ALDH1B1 is crucial for colon tumorigenesis by modulating Wnt\/\u03b2-catenin, notch and PI3K\/Akt signaling pathways. PLoS ONE 10, e0121648 (2015).","journal-title":"PLoS ONE"},{"key":"2735_CR54","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s43018-020-00169-2","volume":"2","author":"J Ma","year":"2021","unstructured":"Ma, J. et al. Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients. Nat. Cancer 2, 233\u2013244 (2021).","journal-title":"Nat. Cancer"},{"key":"2735_CR55","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"K Chang","year":"2013","unstructured":"Chang, K. et al. The cancer genome atlas pan-cancer analysis project. Nat. Genet. 45, 1113\u20131120 (2013).","journal-title":"Nat. Genet."},{"key":"2735_CR56","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2147\/TCRM.S3583","volume":"5","author":"P Comella","year":"2009","unstructured":"Comella, P. et al. Role of oxaliplatin in the treatment of colorectal cancer. Ther. Clin. Risk Manag. 5, 229\u2013238 (2009).","journal-title":"Ther. Clin. Risk Manag."},{"key":"2735_CR57","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.3390\/cancers11101540","volume":"11","author":"V Ruiz de Porras","year":"2019","unstructured":"Ruiz de Porras, V. et al. Tumor expression of cyclin-dependent kinase 5 (Cdk5) is a prognostic biomarker and predicts outcome of oxaliplatin-treated metastatic colorectal cancer patients. Cancers 11, 1540 (2019).","journal-title":"Cancers"},{"key":"2735_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46440-3","volume":"15","author":"J Chang","year":"2024","unstructured":"Chang, J. & Ye, J. C. Bidirectional generation of structure and properties through a single molecular foundation model. Nat. Commun. 15, 2323 (2024).","journal-title":"Nat. Commun."},{"key":"2735_CR59","doi-asserted-by":"publisher","first-page":"2404845","DOI":"10.1002\/advs.202404845","volume":"11","author":"S Zheng","year":"2024","unstructured":"Zheng, S. et al. Cross-modal graph contrastive learning with cellular images. Adv. Sci. 11, 2404845 (2024).","journal-title":"Adv. Sci."},{"key":"2735_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0300906","volume":"19","author":"D Pog\u00e1ny","year":"2024","unstructured":"Pog\u00e1ny, D. & Antal, P. Towards explainable interaction prediction: embedding biological hierarchies into hyperbolic interaction space. PLoS ONE 19, e0300906 (2024).","journal-title":"PLoS ONE"},{"key":"2735_CR61","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1021\/acs.jcim.0c00681","volume":"60","author":"K Yu","year":"2020","unstructured":"Yu, K., Visweswaran, S. & Batmanghelich, K. Semi-supervised hierarchical drug embedding in hyperbolic space. J. Chem. Inf. Model. 60, 5647\u20135657 (2020).","journal-title":"J. Chem. Inf. Model."},{"key":"2735_CR62","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/s43018-019-0018-6","volume":"1","author":"SM Corsello","year":"2020","unstructured":"Corsello, S. M. et al. Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling. Nat. Cancer 1, 235\u2013248 (2020).","journal-title":"Nat. Cancer"},{"key":"2735_CR63","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013607 (2012).","journal-title":"Nature"},{"key":"2735_CR64","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi, M. et al. Next-generation characterization of the cancer cell line encyclopedia. Nature 569, 503\u2013508 (2019).","journal-title":"Nature"},{"key":"2735_CR65","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"2735_CR66","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740 (2011).","journal-title":"Bioinformatics"},{"key":"2735_CR67","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2020","unstructured":"Szklarczyk, D. et al. The STRING database in 2021: customizable protein\u2013protein networks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Res. 49, D605\u2013D612 (2020).","journal-title":"Nucleic Acids Res."},{"key":"2735_CR68","doi-asserted-by":"publisher","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","volume":"47","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Res. 47, D1102\u2013D1109 (2018).","journal-title":"Nucleic Acids Res."},{"key":"2735_CR69","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2015","unstructured":"Colaprico, A. et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 44, e71\u2013e71 (2015).","journal-title":"Nucleic Acids Res."},{"key":"2735_CR70","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173, 400\u2013416.e411 (2018).","journal-title":"Cell"},{"key":"2735_CR71","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.1093\/bioinformatics\/btw344","volume":"32","author":"Z Ding","year":"2016","unstructured":"Ding, Z., Zu, S. & Gu, J. Evaluating the molecule-based prediction of clinical drug responses in cancer. Bioinformatics 32, 2891\u20132895 (2016).","journal-title":"Bioinformatics"},{"key":"2735_CR72","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2106682118","volume":"118","author":"SMC Mourragui","year":"2021","unstructured":"Mourragui, S. M. C. et al. Predicting patient response with models trained on cell lines and patient-derived xenografts by nonlinear transfer learning. Proc. Natl. Acad. Sci. USA. 118, e2106682118 (2021).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"2735_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijc.25242","volume":"127","author":"A Capes-Davis","year":"2010","unstructured":"Capes-Davis, A. et al. Check your cultures! A list of cross-contaminated or misidentified cell lines. Int. J. Cancer 127, 1\u20138 (2010).","journal-title":"Int. J. Cancer"}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02735-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02735-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02735-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:02:42Z","timestamp":1784851362000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-026-02735-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2735"],"URL":"https:\/\/doi.org\/10.1038\/s41746-026-02735-x","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.Z., X.L., N.Q., and X.T. are listed as inventors on a pending Chinese patent application related to the BioGDR framework described in this manuscript. The patent is filed by the Shanghai Institute of Materia Medica, Chinese Academy of Sciences. The full list of inventors includes Mingyue Zheng, Xutong Li, Ning Qu, Xiaochu Tong, Xiangying Xie, Chen Zhang, and Mingyan Xu. The patent, entitled \u201cConstruction and application of a tumor drug sensitivity prediction model\u201d, was filed on February 28, 2025, under application number CN202510234543.8, and is currently pending. The remaining authors declare no competing financial or non-financial interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"572"}}